Načítá se...
Treatment Sequencing in Advanced BRAF-Mutant Melanoma Patients: Current Practice in the United States
Background: Treatment of advanced BRAF-mutant melanoma has changed dramatically in the past 3 years thanks to the approval of new immunotherapy and targeted therapy agents. Objectives: The goal of our survey was to investigate when immunotherapy and targeted therapy are used in the management of adv...
Uloženo v:
| Vydáno v: | J Pharm Technol |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
SAGE Publications
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5998464/ https://ncbi.nlm.nih.gov/pubmed/34860980 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/8755122517747089 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|